BioCentury
ARTICLE | Company News

Aptalis Holdings, Forest Laboratories deal

January 13, 2014 8:00 AM UTC

Forest will acquire gastrointestinal company Aptalis for $2.9 billion in cash. Aptalis markets nine products, including Carafate sucralfate suspension to treat active duodenal ulcers and Zenpep panc...